Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Haemonetics and CSL Plasma have announced an agreement to transfer ownership of Haemonetics' Union, South Carolina, manufacturing facility, operating assets and certain inventories to CSL Plasma.
read more
LSNE has received GMP certification from Brazil's National Health Surveillance Agency - ANVISA following an inspection and audit of its manufacturing facility in Manchester, NH in February.
read more
Catalent announced financial results for the third quarter of fiscal year 2019, which ended March 31, 2019.
read more
WuXi AppTec announced it has acquired Pharmapace, a US-based clinical research services company with expertise of providing high quality biometrics services.
read more
ReForm Biologics has expanded its patent portfolio with the issuance of U.S. Patent No. 10,279,048 (the ‘048 patent).
read more
Harbour BioMed and Chia Tai Tianqing announced they are entering into a strategic alliance to discover, develop and commercialize next-generation biologics.
read more
Adimab announced the expansion of an earlier multi-target research agreement with Regeneron Pharmaceuticals.
read more
Paragon Bioservices announced the appointment of John R. Mosack as the Vice President of Manufacturing in Baltimore and Adam Sachs as the Vice President of Program Management and Strategic Client Alliance.
read more
Catalent announced the BSI has awarded Catalent a global accreditation against the international management standards for environment and Occupational Safety.
read more
Recipharm has launched its end-to-end inhalation offering to provide customers with a fully integrated service from early stage development through to commercial manufacturing.
read more
Vibalogics has increased its single-use bioreactor and purification capacity with a new manufacturing line for its specialist oncolytic virus and viral vector manufacturing services.
read more
Crown Bioscience announced the opening of a new facility in San Diego, CA.
read more
The EC has licensed Dupixent® for use in adults and adolescents 12 years and older as an add-on maintenance treatment for severe asthma with type 2 inflammation.
read more
Mispro Biotech Services announced expansion of its network of vivarium research facilities with the opening of an 18,000-square-foot facility in Broad Hollow Bioscience Park in Farmingdale, NY.
read more
Curadev announced it has licensed its novel lead small molecule Stimulator of Interferon Genes (STING) agonist and associated patents to Takeda Pharmaceutical.
read more